Our results indicate that, in comparison to the prostatitis group, the expression levels of the proinflammatory factors TNF-α and IFN-γ exhibited varying degrees of reduction following treatment with RTX at different dosages. The gene discussed is IFNG; the disease is urogenital neoplasm.